Dorsey & Whitney Trust’s iShares Biotechnology ETF IBB Stock Holding History

Dorsey & Whitney Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$258K	Hold	1,530	–	–	0.01%	613
2025 Q4	$258K	Hold	1,530	–	–	0.01%	603
2025 Q3	$221K	Buy	+1,530	New	+$209K	0.01%	632
2025 Q1	–	Sell	-1,530	Closed	-$202K	–	676
2024 Q4	$202K	Hold	1,530	–	–	0.01%	651
2024 Q3	$223K	Hold	1,530	–	–	0.01%	619
2024 Q2	$210K	Buy	1,530 +10	+0.7%	+$1.33K	0.01%	583
2024 Q1	$209K	Hold	1,520	–	–	0.01%	591
2023 Q4	$206K	Buy	+1,520	New	+$185K	0.02%	572
2022 Q2	–	Sell	-1,630	Closed	-$212K	–	560
2022 Q1	$212K	Hold	1,630	–	–	0.02%	524
2021 Q4	$249K	Sell	1,630 -880	-35%	-$136K	0.02%	464
2021 Q3	$406K	Hold	2,510	–	–	0.04%	328
2021 Q2	$411K	Hold	2,510	–	–	0.04%	321
2021 Q1	$378K	Hold	2,510	–	–	0.04%	335
2020 Q4	$380K	Buy	+2,510	New	+$359K	0.04%	289
2019 Q1	–	Sell	-2,115	Closed	-$204K	–	410
2018 Q4	$204K	Buy	2,115 +190	+10%	+$20.2K	0.04%	334
2018 Q3	$235K	Buy	+1,925	New	+$227K	0.04%	347

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dorsey & Whitney Trust's IBB Position: Q1 2026 in Review

Dorsey & Whitney Trust held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,530 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #613.

Dorsey & Whitney Trust first reported a position in IBB in Q3 2018 and has held it in 16 quarters since. The position peaked at $411K in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Dorsey & Whitney Trust held 1,530 shares of iShares Biotechnology ETF worth $258K as of Q1 2026.
Dorsey & Whitney Trust left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.01% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #613 holding.
Dorsey & Whitney Trust first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 16 quarters since.
Dorsey & Whitney Trust's iShares Biotechnology ETF position peaked at $411K in Q2 2021.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.